Wall Street Zen upgraded shares of Arcutis Biotherapeutics (NASDAQ:ARQT – Free Report) from a buy rating to a strong-buy rating in a research note published on Sunday. Other research analysts have also recently issued reports about the stock. Mizuho increased their price target on shares of Arcutis Biotherapeutics from $32.00 to $37.00 and gave the […]

Acrivon Therapeutics (NASDAQ:ACRV – Get Free Report) was downgraded by stock analysts at Wall Street Zen from a “hold” rating to a “sell” rating in a research report issued to clients and investors on Saturday. ACRV has been the subject of a number of other reports. HC Wainwright reiterated a “buy” rating and issued a […]

Design Therapeutics (NASDAQ:DSGN – Get Free Report) was downgraded by investment analysts at Wall Street Zen from a “hold” rating to a “sell” rating in a note issued to investors on Saturday. DSGN has been the subject of a number of other research reports. Weiss Ratings reaffirmed a “sell (d-)” rating on shares of Design […]

Leerink Partnrs upgraded shares of Design Therapeutics (NASDAQ:DSGN – Free Report) from a hold rating to a strong-buy rating in a research report report published on Wednesday morning,Zacks.com reports. Several other equities analysts have also weighed in on DSGN. Weiss Ratings reissued a “sell (d-)” rating on shares of Design Therapeutics in a report on […]

Design Therapeutics (NASDAQ:DSGN – Get Free Report) was upgraded by equities research analysts at Leerink Partnrs from a “hold” rating to a “strong-buy” rating in a research note issued on Wednesday,Zacks.com reports. A number of other analysts have also recently weighed in on the stock. Royal Bank Of Canada upgraded shares of Design Therapeutics from […]

Aardvark Therapeutics (NASDAQ:AARD – Get Free Report) was upgraded by Raymond James Financial to a “strong-buy” rating in a research note issued to investors on Tuesday, MarketBeat.com reports. Other analysts also recently issued research reports about the stock. Bank of America decreased their price objective on shares of Aardvark Therapeutics from $26.00 to $25.00 and […]